FDA
label_change
· 2019-10-23
FDA Approved: KEPPRA — Supplemental Application (UCB, Inc.)
Summary
The FDA approved a supplemental application for KEPPRA (levetiracetam) submitted by UCB, Inc., likely updating the product labeling. The action indicates a labe…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KEPPRA (LEVETIRACETAM)